303 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

XOMA Royalty Acquisitions

XOMA Royalty has acquired 8 companies and its latest acquisition was Generation Bio Co. on Dec 2025

Unlock 5 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Generation Bio Co.

Dec 2025

Source »
undisclosed
Generation Bio is a biotechnology company that researches and develops gene therapies for the treatment of skeletal muscle diseases and eye disorders.
Mural Oncology PLC

Aug 2025

Source »
$36.2M
-
HilleVax, Inc.

Aug 2025

Source »
$103M
HilleVax is a Massachusetts-based biopharmaceutical company that researches and develops novel vaccines for the treatment of acute gastroenteritis disorders.
LAVA Therapeutics N.V.

Aug 2025

Source »
undisclosed
Lava is a biotechnology company that develops next-generation biospecific antibodies for cancer therapies.
Turnstone Biologics Corp.

Jun 2025

Source »
undisclosed
Turnstone Biologics is a New York-based clinical-stage biotech company that researches and develops TIL therapies for solid tumor treatment in cancer patients.

Frequently Asked Questions about XOMA Royalty

  1. What companies did XOMA Royalty acquire?

    Companies acquired by XOMA Royalty include Generation Bio, Mural Oncology and HilleVax

  2. How many acquisitions does XOMA Royalty have?

    XOMA Royalty has acquired 8 companies including Generation Bio, Mural Oncology and HilleVax.

  1. How many acquisitions did XOMA Royalty make in 2025?

    In 2025 XOMA Royalty acquired 5 companies including Generation Bio, Mural Oncology and HilleVax.